Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours
Clinical trial NCT02303028 · COMPLETED
Trial details
- NCT number
- NCT02303028
- Sponsor
- The Hospital for Sick Children
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-03-01
- Primary completion
- 2022-06-17
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.